Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 456

Similar articles for PubMed (Select 16741578)

1.
2.

Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.

Barkan D, Hedhli D, Yan HG, Huygen K, Glickman MS.

Infect Immun. 2012 Jun;80(6):1958-68. doi: 10.1128/IAI.00021-12. Epub 2012 Mar 19.

3.
4.

Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.

Rao V, Fujiwara N, Porcelli SA, Glickman MS.

J Exp Med. 2005 Feb 21;201(4):535-43. Epub 2005 Feb 14.

5.

The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase.

Glickman MS, Cahill SM, Jacobs WR Jr.

J Biol Chem. 2001 Jan 19;276(3):2228-33. Epub 2000 Nov 22.

6.

Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.

Barkan D, Rao V, Sukenick GD, Glickman MS.

J Bacteriol. 2010 Jul;192(14):3661-8. doi: 10.1128/JB.00312-10. Epub 2010 May 14.

7.
8.

Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern.

Vander Beken S, Al Dulayymi JR, Naessens T, Koza G, Maza-Iglesias M, Rowles R, Theunissen C, De Medts J, Lanckacker E, Baird MS, Grooten J.

Eur J Immunol. 2011 Feb;41(2):450-60. doi: 10.1002/eji.201040719. Epub 2010 Dec 29.

PMID:
21268014
9.

Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Alibaud L, Alahari A, Trivelli X, Ojha AK, Hatfull GF, Guerardel Y, Kremer L.

J Biol Chem. 2010 Jul 9;285(28):21698-707. doi: 10.1074/jbc.M110.125724. Epub 2010 May 10.

10.
11.

Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages.

Indrigo J, Hunter RL Jr, Actor JK.

Microbiology. 2002 Jul;148(Pt 7):1991-8.

PMID:
12101287
12.
13.

Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.

Dao DN, Sweeney K, Hsu T, Gurcha SS, Nascimento IP, Roshevsky D, Besra GS, Chan J, Porcelli SA, Jacobs WR.

PLoS Pathog. 2008 Jun 6;4(6):e1000081. doi: 10.1371/journal.ppat.1000081.

14.

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.

Alahari A, Trivelli X, Guérardel Y, Dover LG, Besra GS, Sacchettini JC, Reynolds RC, Coxon GD, Kremer L.

PLoS One. 2007 Dec 19;2(12):e1343.

15.

Anti-cord factor (trehalose 6,6'dimycolate) IgG antibody in tuberculosis patients recognizes mycolic acid subclasses.

Pan J, Fujiwara N, Oka S, Maekura R, Ogura T, Yano I.

Microbiol Immunol. 1999;43(9):863-9.

PMID:
10553679
16.

Apoptosis modulation by mycolic acid, tuberculostearic acid and trehalose 6,6'-dimycolate.

Nuzzo I, Galdiero M, Bentivoglio C, Galdiero R, Romano Carratelli C.

J Infect. 2002 May;44(4):229-35.

PMID:
12099729
18.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk